Breast Screening
Cervical Screening
Bowel Screening
Diabetic Retina Screening

Latest News
  • Bowel cancer: Ireland’s second deadliest cancer but preventable - BowelScreen highlights Bowel Cancer Awareness Month
    - 03 April 2018
  • Let’s Get Serious About Preventing Cervical Cancer - Pearl of Wisdom Campaign 2018
    - 26 January 2018
  • HSE publishes External Review by Professor Robert JC Steele of Safety Incident Management response to Wexford General Hospital bowel screening incident
    - 24 January 2018
  • *
  • NSS Accessibility
  • Screening Promotion


Welcome to the National Screening Service Website

The National Screening Service was established by the Minister for Health and Children in January 2007. The establishment followed the launch of a Strategy for Cancer Control in Ireland 2006 (pdf file), which advocates a comprehensive cancer control policy programme in Ireland.

The Strategy examined prevention, screening, detection, treatment and management of cancer in Ireland in coming years and recommended the former Board of the National Screening Service.

The National Screening Service (NSS) encompasses BreastCheck - The National Breast Screening Programme, CervicalCheck - The National Cervical Screening Programme, BowelScreen – The National Bowel Screening Programme and Diabetic RetinaScreen – The National Diabetic Retinal Screening Programme.

The former Board of the NSS also had a mandate that included a policy development and advisory role to the Minister for Health and Children relating to other potential cancer screening programmes.

At the request of the Minister for Health and Children the former Board of the NSS undertook a review of the Human Papolloma Virus (HPV) vaccines and reviews of the rationale for the introduction of national population based bladder, prostate and lung cancer screening programmes.

The NSS has also established an Expert Group on Hereditary Cancer Risk and has hosted the first ever interagency lung cancer research forum.

Further information on all these developments is available here.

Media Calls:
For press calls please call the Communications Team 01 865 9300